M-リボミック(4591) RIBOMIC USA Inc. Safe-to-Proceed Under IND to Initiate Clinical Trials of RBM-007 for Treatment of Age-related Macular Degeneration
2018/07/23
ブックマーク
メモを書く
/
-
読み込み中…